Loading clinical trials...
Loading clinical trials...
The purpose of the study was to examine the emotional state of the patients with neurological disorders. The evaluation was conducted with DASS-21 scale over 40 patients.
The Depression, Anxiety and Stress Scale - 21 Items (DASS-21) is a set of three self-report scales designed to measure the emotional states of depression, anxiety and stress.The DASS-21 should not be used to replace a face to face clinical interview.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Physical therapy clinic Trevlakis Emmanouil
Thessaloniki, Greece
Start Date
December 1, 2021
Primary Completion Date
February 1, 2022
Completion Date
February 1, 2022
Last Updated
April 12, 2022
35
ACTUAL participants
Lead Sponsor
International Hellenic University
NCT07478393
NCT07456631
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions